GLP-1 clinical trials in Indiana: 19 recruiting now
30 sites in 11 Indiana cities. Registry checked October 2, 2026.
Screening for a study can take weeks. The cheapest program today is Strut Health.
No insurance needed.
- Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →You pick Weight Loss, then a five-minute online visit
- Shed$199 a month30% off first month with code Shed10compounded semaglutideCheck price →A health form first, then you choose your plan
Weight-loss studies (5)
Weight-loss study of tirzepatide
Where: Indianapolis
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people lose weight.
Free to join
Who can join: Children and teens 12 to 17 with obesity.
Study record on ClinicalTrials.gov
Indiana University Health University Hospital, Indianapolis
Weight-loss study of orforglipron
Where: Indianapolis
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.
Free to join
Who can join: Children and teens 6 to 17 with obesity.
Study record on ClinicalTrials.gov
Riley Hospital for Children, Indianapolis
Weight-loss study of cagrilintide
Where: Indianapolis
What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.
Free to join
Who can join: Children and teens 8 to 18 who are overweight.
Study record on ClinicalTrials.gov
IU Health - Riley Physicians Endo-Diab, Indianapolis
Show 2 more studies
Weight-loss study of semaglutide
Where: Indianapolis
What: Tests whether a GLP-1 medicine from Novo Nordisk, semaglutide, can help people lose weight.
Free to join
Who can join: Adults 18+ who are overweight.
Study record on ClinicalTrials.gov
Midwest Inst For Clin Res, Indianapolis
Weight-loss study of cagrilintide
Where: Indianapolis
What: Tests whether a study medicine from Novo Nordisk, cagrilintide, can help people lose weight.
Free to join
Who can join: Adults 18+ who are overweight, BMI 27+.
Study record on ClinicalTrials.gov
Midwest Inst For Clin Res, Indianapolis
Type 2 diabetes studies (4)
Type 2 diabetes study of cagrisema
Where: Indianapolis
What: Tests whether a study medicine from Novo Nordisk, cagrisema, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Children and teens 10 to 18 with type 2 diabetes.
Study record on ClinicalTrials.gov
Riley Hospital For Children, Indianapolis
Type 2 diabetes study of semaglutide
Where: Evansville
What: Tests whether a GLP-1 medicine, semaglutide, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18+ with type 2 diabetes, BMI 23+.
Study record on ClinicalTrials.gov
Research Site, Evansville
Type 2 diabetes study of LY3457263
Where: Brownsburg
What: Tests whether an investigational medicine from Lilly, LY3457263, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes, BMI 27+.
Call the site: 3178528280Study record on ClinicalTrials.gov
Investigators Research Group, Brownsburg. 3178528280
Show 1 more study
Type 2 diabetes study of UBT251
Where: Indianapolis
What: Tests whether an investigational medicine from Novo Nordisk, UBT251, can help people with type 2 diabetes lower blood sugar.
Free to join
Who can join: Adults 18 to 75 with type 2 diabetes.
Study record on ClinicalTrials.gov
Midwest Inst For Clin Res, Indianapolis
Other GLP-1 studies in Indiana (10)
Fatty liver disease (MASLD) study of retatrutide
Where: Indianapolis, New Albany, Newburgh and 1 more city
What: Tests whether a GLP-1, GIP and glucagon medicine from Lilly, retatrutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (MASLD), BMI 25+.
Call the site: 317-278-1652Study record on ClinicalTrials.gov
Indiana University Health University Hospital, Indianapolis. 317-278-1652
Gastroenterology Health Partners, New Albany. 812-206-1702
Deaconess Clinic- Gateway, Newburgh. 812-490-4505
Digestive Research Alliance of Michiana, South Bend. 574-904-9617
Peripheral artery disease study of orforglipron
Where: Hammond, Indianapolis, Munster and 1 more city
What: Tests whether a GLP-1 medicine from Lilly, orforglipron, can help people improve blood flow in the legs.
Free to join
Who can join: Adults 18+ with peripheral artery disease (poor blood flow in the legs), BMI 23+.
Call the site: 219-803-6649Study record on ClinicalTrials.gov
ASHA Clinical Research - Munster, LLC, Hammond. 219-803-6649
Indiana University Health Methodist Hospital, Indianapolis
Cardiovascular Research of Northwest Indiana, Munster. 219-934-4200
Deaconess Clinic- Gateway, Newburgh. 812-490-4505
Fatty liver disease with liver scarring study of survodutide
Where: Hammond and South Bend
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
Call the site: 833-602-2368Study record on ClinicalTrials.gov
ASHA Clinical Research - Munster, LLC, Hammond. 833-602-2368
Digestive Research Alliance of Michiana, South Bend. 833-602-2368
Show 7 more studies
Fatty liver disease (also called MASH or NASH) study of survodutide
Where: Hammond and South Bend
What: Tests whether a GLP-1 and glucagon medicine from Boehringer Ingelheim, survodutide, can help people reduce liver fat.
Free to join
Who can join: Adults 18+ with fatty liver disease (also called MASH or NASH), BMI 25+.
Call the site: 833-602-2368Study record on ClinicalTrials.gov
ASHA Clinical Research - Munster, LLC, Hammond. 833-602-2368
Digestive Research Alliance of Michiana, South Bend. 833-602-2368
Ulcerative colitis study of tirzepatide
Where: Indianapolis and New Albany
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with ulcerative colitis calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with ulcerative colitis, BMI 27+.
Call the site: 812-206-1702Study record on ClinicalTrials.gov
Indiana University Health University Hospital, Indianapolis
Gastroenterology Health Partners, New Albany. 812-206-1702
Crohn's disease study of tirzepatide
Where: Indianapolis and New Albany
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people with Crohn's disease calm gut inflammation.
Free to join
Who can join: Adults 18 to 70 with Crohn's disease, BMI 27+.
Call the site: 812-206-1702Study record on ClinicalTrials.gov
Indiana University Health University Hospital, Indianapolis
Gastroenterology Health Partners, New Albany. 812-206-1702
Psoriasis study of tirzepatide
Where: Indianapolis and Plainfield
What: Tests whether a GLP-1 and GIP medicine from Lilly, tirzepatide, can help people calm psoriasis.
Free to join
Who can join: Adults 18+ with psoriasis, BMI 27+.
Call the site: 317-516-5030Study record on ClinicalTrials.gov
Dawes Fretzin Clinical Research Group, LLC, Indianapolis. 317-516-5030
The Indiana Clinical Trials Center, PC, Plainfield. 317-837-6082
Fatty liver disease with liver scarring study of tirzepatide
Where: Indianapolis
What: Tests whether a GLP-1 and GIP medicine, tirzepatide, can help people reduce liver fat.
Free to join
Who can join: Adults 18 to 75 with fatty liver disease (MASLD) with liver scarring (fibrosis), BMI 35+.
Study record on ClinicalTrials.gov
Indiana University, Indianapolis
Chronic kidney disease study of NNC0519-0130
Where: Valparaiso
What: Tests whether an investigational medicine from Novo Nordisk, NNC0519-0130, can help people with chronic kidney disease protect their kidneys.
Free to join
Who can join: Adults 18+ with chronic kidney disease, BMI 27+.
Study record on ClinicalTrials.gov
Velocity Clin. Res Valparaiso, Valparaiso
Blood glucose study
Where: West Lafayette
Free to join
Who can join: Adults 18 to 45 with healthy participant study, BMI 18.5+.
Call the site: 765-496-6275Study record on ClinicalTrials.gov
Clinical Research Center at Purdue University, West Lafayette. 765-496-6275
Source: ClinicalTrials.gov, the federal registry, read October 2, 2026. Open a study's registry record before you call: it can close to new participants at any time. GLP Chart does not enroll anyone, is not paid for clinical-trial referrals and has no relationship with any sponsor or site on this page.
Clinical trials by state
Every state with a GLP-1 study recruiting today. 48 of them.
- Alabama (17)
- Arizona (22)
- Arkansas (6)
- California (51)
- Colorado (17)
- Connecticut (13)
- Delaware (1)
- District of Columbia (1)
- Florida (42)
- Georgia (23)
- Hawaii (5)
- Idaho (12)
- Illinois (30)
- Indiana (19)
- Iowa (10)
- Kansas (15)
- Kentucky (15)
- Louisiana (15)
- Maine (1)
- Maryland (22)
- Massachusetts (19)
- Michigan (20)
- Minnesota (18)
- Mississippi (6)
- Missouri (21)
- Montana (3)
- Nebraska (5)
- Nevada (13)
- New Hampshire (3)
- New Jersey (12)
- New Mexico (5)
- New York (30)
- North Carolina (30)
- North Dakota (5)
- Ohio (28)
- Oklahoma (12)
- Oregon (5)
- Pennsylvania (33)
- Rhode Island (6)
- South Carolina (24)
- South Dakota (2)
- Tennessee (26)
- Texas (56)
- Utah (14)
- Virginia (28)
- Washington (23)
- West Virginia (5)
- Wisconsin (7)
